Table 1.

Patient demographics at baseline

	n	%
	83	–
Age, median and range	49 (22–78)
Tumor size, median (mm) and range	30 (20–80)
Clinical nodal status
N0	40	48.2
N1	30	36.1
N2	8	9.6
N3	1	1.2
Nx	4	4.9
Hormone receptor status
Negative	26	31.3
Positive	57	68.7
Menopausal status
Pre-menopausal	54	65.1
Post-menopausal	29	34.9
Tumor stage
II	65	78.3
III	18	21.7
Histologic grade
1	5	6.0
2	28	33.7
3	32	38.6
Unknown	18	21.7